LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 572 pages found matching <script>alert('What_Security?')</script>- FDA Needs To Ban Accutane
Sep-20-06 Austin, TX: Unfortunately hundreds of parents already know that Accutane can cause some teenagers to commit suicide. But new evidence of a link between the acne drug and depression in the journal Neuropsychopharmacology , will hopefully put an end to the years of claims by Hoffman-LaRoche that its drug is not responsible for the suicides. Scien... - J&J Can't Settle Ortho Evra Birth Control Patch Cases Fast Enough
Sep-18-06 Whitehouse, NJ: More than 500 claimants are seeking "substantial compensatory and, where available, punitive damages," from Johnson & Johnson for injuries and deaths related to the Ortho Evra birth control patch, according to the company's Second Quarter Report filed with the SEC. However, if legal analysts are correct, J&J ain't seen nothin... - 500 Ortho Evra Birth Control Patch Victims Sue Johnson & Johnson
Sep-17-06 New Brunswick, NJ According to Johnson & Johnson's latest SEC filing for the Second Quarter of 2006, the company is currently facing 500 claimants in lawsuits related to deaths and injuries caused by the Ortho Evra birth control patch . "These claimants," the filing notes, "seek substantial compensatory and, where available, punitive damages. ... - Boston Scientific and Guidant Off to Texas Slaughterhouse
Sep-6-06 Corpus Christi, TX The first, but by no means the last, Guidant trial is scheduled to begin on September 18, 2006, in Neuces County District Court in Corpus Christi, Texas before Judge Jack Hunter. The two plaintiffs, Louis Motal, 63, and Bernice Hinojosa, 65, are surviving patients implanted with Guidant's Ventak Prizm 2 defibrillators in 2001. The law... - Nursing Home Inspection Process Full Of Corruption
Sep-2-06 Nursing home companies invest heavily in local politicians. They do so to ensure the failure of efforts to pass legislation unfavorable to the industry and to buy protection against fines and penalties levied by state officials charged with investigating and monitoring the industry. According to a September 2006 report by Consumer Reports, "they wield con... - Roche puts Accutane profits over Lives of Consumers
Aug-31-06 In 1985, Accutane's package insert directed at doctors first mentioned reports of depression in patients taking the acne drug, which means that more than 20 years ago, Hoffman-LaRoche at least suspected there might be a risk of depression and suicide by persons taking the drug. However, Roche's financial records show that the company is not about to let a... - Big Pharma Bankrupting US Health Care System
Aug-29-06 ig Pharma is bankrupting the nation's health care system by convincing prescribing doctors to over-medicate patients with expensive psychiatric drugs and then send the bills to government programs like Medicaid and Medicare. The peddling of the new generation of psychiatric drugs that include the selective serotonin reuptake inhibitors antidepressants (S... - Fen-Phen May Cause Rummage Sale of Wyeth Assets - Fen-Phen Trial Resources
Aug-23-06 On August 18, 2006, Bloomberg News reported that Wyeth has faced more than 175,000 claims since fen-phen was removed from the market, and that over the past 9 years, the company has settled many claims without forcing fen-phen users to file a lawsuit. All total, the company has set aside more than $21 billion to cover legal costs and settlements since... - Lawmakers say FDA better Clean Up its Act
Aug-18-06 For six years, the Bush administration has placed pharmaceutical industry interests ahead of public interest by appointing persons with strong ties to drug companies to high level positions at the FDA. As a result, Congressional investigations and a recent survey indicate that the health and safety of all Americans is being compromised. On July 20, 200... - Advice to Employers: Pay workers now rather than Later
Aug-12-06 "Employers would be well advised to compensate their employees before they are taken to court," says Tom Emmitt, head litigation attorney at United Employees Law Group, PC. "Employer's biggest fears are class action and individual lawsuits. We will take the employer to court and collect not only back wages and overtime owed, but a variety of penalties and... - Credit Card Abuse: How Universal Default Affects You
Aug-6-06 You may not be aware of it, but the credit card companies are watching you. Even if you already knew this, they are probably watching more closely than you think. In addition to watching your every move on their product, they are also watching when you pay your bills, whether or not you apply for other credit cards, and whether or not your credit score ha... - Zyprexa Lawsuits - Eli Lilly May Lose Insurance Coverage
Aug-3-06 In the company's first quarter report for 2006, Eli Lilly says it is having problems with insurance coverage. "We have experienced difficulties in obtaining product liability insurance due to a very restrictive insurance market," the report says, "and therefore will be largely self-insured for future product liability losses." Although Lilly has cover... - GlaxoSmithKline Sued Over Paxil Birth Defects
Jul-29-06 A lawsuit was filed against GlaxoSmithKline on July 28, 2006, in Philadelphia on behalf of Adrian Vasquez, who was born on April 19, 2004, with birth defects as a result of his mother having been prescribed Paxil during pregnancy. Paxil belongs to the class of antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). At birth, Ad... - Drug Companies Still Peddling Risperdal and Zyprexa For Off-Label Use
Jun-17-06 According to Kelly O'Meara, author of the newly released book, Psyched Out, America has a drug problem. "It's not as covert as those illicit and illegal "Just Say No" drugs," she says, "but, rather, Americans have become drug users by way of being diagnosed as suffering from one or a number of alleged mental disorders." "Sharing one's feelings with a doc... - Congressmen on War Path over FDA approval of Ketek
Jun-12-06 French drug giant Sanofi-Aventis has stopped enrolling pediatric patients in clinical trials for Ketek. On June 9, 2006, the drug maker said it halted tests on its own to ensure that trials of the drug complied with FDA requirements. The company denied that the studies were suspended because of safety concerns. However, the move jives with the recently in... - Beverly Enterprises - Poster Child Of Fraud And Neglect In Nursing Home Industry
Jun-1-06 Nowhere in the nursing home industry is the corruption, patient neglect and abuse and Medicare and Medicaid fraud more blatant than within the giant nursing home chain of Beverly Enterprises. Based in Fort Smith, it reportedly operates more than 400 nursing facilities, assisted living centers and hospices in 23 states and the District of Columbia. The cha... - Tequin's Serious Injuries - Bristol-Myers Feigns Ignorance
May-1-06 On April 27, 2006, Dow Jones reported that Bristol-Myers Squibb had decided to stop selling Tequin, an antibiotic found to increase the risk of blood-sugar problems. BMS made a "recent decision to stop all our commercialization efforts" for Tequin and to return the rights to Kyorin, Dow quoted Chief Financial Officer, Andrew Bonfield, as saying. BMS licen... - Ortho-McNeil knew Ortho Evra Patch was Lethal
Apr-19-06 Documents have surfaced in litigation that show Ortho-McNeil has been analyzing the FDA's death and injury reports on women using the Ortho Evra birth-control patch, and has charts that show a higher rate of blood clots and deaths in women on the patch when compared to women who take birth-control pills. In addition, according to a November 11, 2005, arti... - Guidant Defibrillators are Disposed Of
Apr-5-06 The second time Burton Greene's Guidant defibrillator malfunctioned he was rushed to hospital, but it damaged his kidneys. The third time, he passed away. "He was only 60 years old and the doctor said he had many good years ahead," said his wife Lynda. Lynda Greene, Fredericksburg, Virginia: It was January, 2006. My husband came inside the house to res... - Gambro Healthcare - Dialysis Fraud Pays Big Bucks
Mar-29-06 Medicare payments for dialysis cost the US government $5 billion a year. The global market for chronic dialysis services is worth approximately $43 billion and the US market is the largest in the world in terms of value. Worldwide, by the end of 2005, the number of dialysis patients reached 1.5 million. Of that number, approximately 23% patients were trea...